gall bladder carcinoma

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cholangiocarcinoma, Gall Bladder Carcinoma Trial in Worldwide (Gemcitabine, Cisplatin, Capecitabine)

Active, not recruiting
  • Cholangiocarcinoma
  • Gall Bladder Carcinoma
  • Bankstown, New South Wales, Australia
  • +66 more
Jan 22, 2023

Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

Recruiting
  • Biliary Tract Cancer (CCA)
  • +4 more
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Jun 23, 2022

RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY

Recruiting
  • Bile Duct Neoplasms
  • Gall Bladder Carcinoma
  • Radio frequency ablation
  • Hyderabad, Telangana, India
    Asian Institute of Gastroenterology
Apr 1, 2022

Completion Radical Cholecystectomy Determine Survival in

Completed
  • Gall Bladder Carcinoma
  • Survival
  • Curative surgery
  • (no location specified)
Nov 5, 2021

Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

Active, not recruiting
  • Cholangiocarcinoma
  • +3 more
  • Durvalumab
  • +3 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Oct 14, 2021

Biliary Carcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Trial in Tampa (Cisplatin, Gemcitabine, Copanlisib)

Completed
  • Biliary Carcinoma
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 3, 2021

Cholangiocarcinoma, Gall Bladder Carcinoma Trial in Tianjin (Gemcitabine, Capecitabine)

Recruiting
  • Cholangiocarcinoma
  • Gall Bladder Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute and Hospital
Dec 17, 2018

System of Biliary Malignancies Based on Special Disease Database

Unknown status
  • Cholangiocarcinoma
  • +2 more
    • Shanghai, Shanghai, China
      Zhaohui Tang
    Apr 13, 2018